...
首页> 外文期刊>Respiratory Medicine Case Reports >Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
【24h】

Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism

机译:治疗肺血栓栓塞时利伐沙班和达比加群引起的白细胞碎裂性血管炎的病例

获取原文

摘要

Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism.
机译:白细胞碎裂性血管炎是一种以嗜中性粒细胞炎症为特征的疾病,主要限于皮肤毛细血管后浅静脉。这种情况可能是特发性的,也可能有明确的原因。利伐沙班和达比加群因其疗效和安全性已被广泛用作华法林的替代品。在此病例报告中,我们描述了由利伐沙班和达比加群酯诱导的白细胞碎裂性血管炎,这是在肺血栓栓塞治疗期间发展的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号